Ad
AMGN Stock - Amgen Stock Trading
About | Amgen Inc. (NASDAQ:AMGN)
Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).
Quote | Amgen Inc. (NASDAQ:AMGN)
| Last: | $320.56 |
|---|---|
| Change Percent: | -0.1% |
| Open: | $324.7 |
| Close: | $320.56 |
| High: | $326.97 |
| Low: | $319 |
| Volume: | 2,094,409 |
| Last Trade Date Time: | 09/06/2024 03:00:00 am |
News | Amgen Inc. (NASDAQ:AMGN)
-
2024-09-07 01:00:44 ET Summary "The Dow® [adds a stock] if the company has an excellent reputation, demonstrates sustained growth, and is of interest to a large number of investors... Sector representation...is also a consideration.” - Dow Jones & Co. The highest-y...
-
2024-09-05 13:47:04 ET Amgen Inc. (AMGN) Wells Fargo 2024 Healthcare Conference Call September 5, 2024 09:30 ET Company Participants Justin Claeys - Vice President of Investor Relations Jay Bradner - Executive Vice President, Research and Development & Chief Scie...
Message Board Posts | Amgen Inc. (NASDAQ:AMGN)
| Subject | By | Source | When |
|---|---|---|---|
| AMGEN INC is having a great day! | MiamiGent | investorshub | 11/08/2022 5:04:41 PM |
| whytestocks: $AMGN News Article - Why Amgen Is Up More Than 6% Today | whytestocks | investorshangout | 10/11/2022 6:45:49 PM |
| whytestocks: $AMGN News Article - AMGEN OUTLINES GROWTH STRATEGY THROUGH 2030 AT VIRTUAL BUSINESS RE | whytestocks | investorshangout | 02/08/2022 4:25:52 PM |
| WAS SUPPOSED TO BE BIG IN pm | ernie44 | investorshub | 02/04/2022 2:30:34 PM |
| I was reading on another board where someone | all the way up green | investorshub | 01/05/2022 4:44:01 AM |
News, Short Squeeze, Breakout and More Instantly...
Ad
-
AMGEN TO PRESENT AT THE 2024 WELLS FARGO HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif. , Aug. 30, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the 2024 Wells Fargo Healthcare Conference at 9:30 a.m. ET on Thursday , Sept. 5, 2024. Pete...
-
AMGEN TO PRESENT AT THE MORGAN STANLEY 22ND ANNUAL GLOBAL HEALTHCARE CONFERENCE PR Newswire THOUSAND OAKS, Calif. , Aug. 29, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will present at the Morgan Stanley 22 nd Annual Global Healthcare Conference at 9:15 a.m. E...
-
2024-08-25 18:30:00 ET Which income investors want to buy stocks with dividends likely to decline and iffy businesses? None. Instead, income investors want practically unstoppable dividend stocks. Three Motley Fool contributors think they've identified healthcare stocks that fit the...
Important Investor News Alert (OTC: AABB)
-
LAS VEGAS, Aug. 28, 2024 (GLOBE NEWSWIRE) -- Asia Broadband Inc. (OTC: AABB) (“AABB” or the “Company”) is pleased to announce that the Company has been thrilled with the rise in gold and silver prices this year and the corresponding increases to AABB’s quarterly...